View in EDS HTML Full Text PDF Full Text

Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer.

Saved in:

Bibliographic Details
Title:	Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer.
Authors:	Ma, Ge¹, Huang, Huaxing^1,2, Li, Minghui¹, Li, Li³, Kong, Peng¹, Zhu, Yichao^4,5, Xia, Tiansong¹, Wang, Shui¹ ws0801@hotmail.com.
Source:	Cancer Biomarkers. 2018, Vol. 22 Issue 3, p405-415. 11p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	15740153
DOI:	10.3233/CBM-170986